Multi-model Image of Immunosuppressive Agents in TAO

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 15, 2021

Primary Completion Date

December 1, 2024

Study Completion Date

December 1, 2025

Conditions

Thyroid Associated Ophthalmopathy

Interventions

DRUG

immunosuppressive agent

patients with TAO recruited in this study will administrated with immunosuppressive agent per day

Trial Locations (1)

RECRUITING

Zhongshan Ophthalmic Center, Guangzhou

All Listed Sponsors

lead

Sun Yat-sen University

OTHER